Drug Discovery App CS WP
-
Characterization Of The Sinclair Nanopig™ For Biopharmaceuticals Safety Assessment
1/9/2025
Discover groundbreaking data that supports the use of the Sinclair Nanopig™ to reduce reliance on traditional non-rodent species in drug development, validating its value in drug safety studies.
-
Advancing Drug Safety And Improving R&D Productivity With The Liver-Chip S1
12/10/2024
Explore how the Emulate Liver-Chip S1 revolutionizes predictive toxicology by mimicking human liver biology, achieving superior sensitivity and specificity.
-
Depth Filters For The Clarification Of AAV
11/27/2024
Explore study results demonstrating the ability of Sartoclear® depth filters to deliver high performance for AAV clarification, ensuring scalability, high recovery rates, and robust filtration.
-
Aseptic Filling Solution Enhances Sterility Assurance for Pharma Manufacturer
11/21/2024
Emergent BioSolutions upgraded its Winnipeg site with the Cytiva SA25 aseptic filling workcell to improve sterility assurance, product flexibility, and regulatory compliance for CGT manufacturing.
-
A Human-Relevant Model Of The Liver Sinusoid
11/7/2024
This organ-on-a-chip model minimizes drug absorption while maintaining the essential architecture. Explore the specifications of this product engineered to model the human liver.
-
Perspectives On Performance, Scalability, And Regulatory Compliance
10/28/2024
Here, we discuss the challenges and solutions for cell and gene therapies, focusing on performance, scalability, and regulatory compliance to accelerate commercialization and improve patient access.
-
Optimizing Time And Cost Efficiency In Cell Line Development
10/28/2024
Discover a system that automates mAb purification, reducing time and costs in cell line development while improving reproducibility, with faster processing than traditional methods.
-
Facilitating Efficient Clone Selection And Enabling High-Throughput Clarification And Purification Processes
10/28/2024
Discover a combination that enables efficient clone selection and automated purification, improving bioprocessing speed, and accelerating biotherapeutic development.
-
Reliable Proliferation And Differentiation Of Desired T Cell Subpopulations With CellGenix® Recombinant Human Interleukin-2 (IL-2)
10/28/2024
This study evaluates a cost-effective alternative to Proleukin® for expanding T cells that demonstrates comparable performance across cell viability, subpopulation ratios, and clinical consistency.
-
Enhancing Process And QC For Multi-Column Chromatography
10/16/2024
Explore two innovative technologies that address major purification challenges in DSP: continuous multi-column chromatography and advanced chromatography or liquid chromatography-mass spectrometry.